Area of research
Genetics · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Connective tissue disorders research, Aortic Disease and Treatment Approaches, Diabetes, Cardiovascular Risks, and Lipoproteins, and Cardiovascular Function and Risk Factors.
Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims database.
Lean body mass index and hypertension risk in men: a nationwide epidemiological cohort study.
Inverse Agonist Activity of Angiotensin II Receptor Blocker Is Crucial for Prevention of Progressive Aortic Dilatation in Marfan Syndrome.
Population attributable fraction of modifiable risk factors for incident hypertension: an analysis of large-scale epidemiological cohort.
Effect of sodium-glucose cotransporter-2 inhibitors on kidney outcomes of individuals with type 2 diabetes according to blood pressure levels.
Integrating ECG Into the Mayo Score Enhances Genotype Prediction in Hypertrophic Cardiomyopathy.
In response to lean body mass index and hypertension risk in men: a nationwide epidemiological cohort study.
Low-Density-Lipoprotein Cholesterol Control and Treatment Status 1 Year after the Initial Health Checkup in Individuals with Referral-Level LDL Cholesterol.
Predicted Lean Body Mass and the Risk of Adverse Kidney Outcomes in Men
SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study.
Parkinson Disease imposes Risk of Kidney Function Decline.
Association between depression and risk of ischaemic stroke in patients with atrial fibrillation.
Myelodysplastic syndromes and risk of kidney function decline: findings from a nationwide Japanese cohort study.
Impact of Cardiovascular-Kidney-Metabolic Syndrome on Cancer Development: Insights From a Nationwide Database Study.
Insomnia and the Risk of Atrial Fibrillation: A Nationwide, Real-World Cohort Study.
Structural and Signaling Mechanisms of Aortic Wall Failure in Heritable Thoracic Aortic Disease
Kidney outcomes with SGLT2 inhibitor versus DPP4 inhibitor use in older adults with diabetes.
Exploring Novel Therapeutics for Pulmonary Arterial Hypertension.
Effect of SGLT2i on kidney outcomes of individuals with type 2 diabetes according to body mass index: nationwide cohort study.
Dose-dependent association between estimated glomerular filtration rate and the subsequent risk of depression: An analysis of a nationwide epidemiological dataset.
Differences in the association of lifestyle-related modifiable risk factors with incident cardiovascular disease between individuals with and without diabetes.
Frailty and its components and cardiovascular outcomes in older adults: A nationwide epidemiological study.
Perivascular inflammation in the progression of aortic aneurysms in Marfan syndrome.
Direct evaluation of antiplatelet therapy in coronary artery disease by comprehensive image-based profiling of circulating platelets.
Prognostic Factors Associated With Early Recovery From Veno-Arterial Extracorporeal Membrane Oxygenation Support in Patients With Fulminant Myocarditis.
Blood pressure control and treatment status at 1 year after the first health check-up in individuals with observed referral-level blood pressure.
PIEZO1 as a potential therapeutic target in Marfan syndrome.
Sodium Polystyrene Sulfonate and Heart Failure Risk: A Comparative Study With Calcium Polystyrene Sulfonate.
Gender differences in the prescription of SGLT2 inhibitors in chronic kidney disease: A real-world database study.
Age-Dependent Relationship of Physical Inactivity With Incident Cardiovascular Disease: Analysis of a Large Japanese Cohort.